Sort   by:  
 Page size 
GenomicsCharacterization of Functional Methylomes by Next-Generation Methylation Capture Sequencing
Comprehensive analysis of the human adipose epigenome by transcriptome, open chromatin and methylome sequencing studies.
ORGANISM(S): Homo sapiens 
2015-05-01 | E-MTAB-3181 | biostudies-arrayexpress
UnknownAutomated detection and delineation of lymph nodes in haematoxylin & eosin stained digitised slides.
Not available
S-EPMC9932489 | biostudies-literature
UnknownBiopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial.
Not available
S-EPMC5363605 | biostudies-literature
UnknownEpstein-Barr virus and mismatch repair deficiency status differ between oesophageal and gastric cancer: A large multi-centre study.
Not available
S-EPMC5914544 | biostudies-literature
UnknownPharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) Chemotherapy.
Not available
S-EPMC6175041 | biostudies-literature
UnknownSafety and Efficacy of the Addition of Lapatinib to Perioperative Chemotherapy for Resectable HER2-Positive Gastroesophageal Adenocarcinoma: A Randomized Phase 2 Clinical Trial.
Not available
S-EPMC6587151 | biostudies-literature
UnknownReduced genomic tumor heterogeneity after neoadjuvant chemotherapy is related to favorable outcome in patients with esophageal adenocarcinoma.
Not available
S-EPMC5190081 | biostudies-literature
UnknownMismatch Repair Deficiency, Microsatellite Instability, and Survival: An Exploratory Analysis of the Medical Research Council Adjuvant Gastric Infusional Chemotherapy (MAGIC) Trial.
Not available
S-EPMC5824280 | biostudies-literature
UnknownIncreasing frequency of gene copy number aberrations is associated with immunosuppression and predicts poor prognosis in gastric adenocarcinoma.
Not available
S-EPMC10364690 | biostudies-literature
UnknownPeri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, open-label, randomised phase 2-3 trial.
Not available
S-EPMC5337626 | biostudies-literature
Sort   by:  
 Page size